Antiretroviral Therapy

ADHERENCIA AL TRATAMIENTO ANTIRRETROVIRAL EN PERSONAS CON VIH EN TAMAULIPAS, MÉXICO

Medication Adherence / Logistic Regression / Antiretroviral Therapy / Hiv Infection / Health Status / Health System / Cross sectional Study / Ministry of Health / Health System / Cross sectional Study / Ministry of Health

Exposición a antirretrovirales y crecimiento en una cohorte de niños no infectados, hijos de madre con VIH positivo

Growth / Cephalometry / Antiretroviral Therapy / Prospective studies / Pregnancy / Humans / Low Birth Weight / Female / Hiv Infection / Risk factors / Newborn Infant / Adult / Highly Active Antiretroviral Therapy / Body Weight / Risk Factors / Body Height / Humans / Low Birth Weight / Female / Hiv Infection / Risk factors / Newborn Infant / Adult / Highly Active Antiretroviral Therapy / Body Weight / Risk Factors / Body Height

Evolución de la prevalencia de infección por el VIH y de las conductas de riesgo en varones homo/bisexuales

Antiretroviral Therapy / Sexual Behavior / Hiv Infection / Prevalence / Risk Behavior

Evolución de la prevalencia de infección por el VIH y de las conductas de riesgo en varones homo/bisexuales

Antiretroviral Therapy / Sexual Behavior / Hiv Infection / Prevalence / Risk Behavior

Tratamiento antirretroviral de la infección por el VIH

Medical Microbiology / Quality of life / Antiretroviral Therapy / Drugs / Humans / Hiv Infection / Knowledge base / Combination drug therapy / Chronic Liver Disease / JAMA / Acquired immunodeficiency syndrome / Viral Load / Hiv Infection / Knowledge base / Combination drug therapy / Chronic Liver Disease / JAMA / Acquired immunodeficiency syndrome / Viral Load

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Resistencias genotípicas en pacientes con VIH-1 y grados de viremia persistentemente bajos

Medical Microbiology / HIV / Antiretroviral Therapy / Humans / HIV protease / Highly Active Antiretroviral Therapy / Enfermedades / Viral Load / Highly Active Antiretroviral Therapy / Enfermedades / Viral Load
Copyright © 2017 DATOSPDF Inc.